Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.
Lena Fischer-RiepeSareetha KailayangiriKatharina ZimmermannRita PfeiferMichael AignerBianca AltvaterSascha KretschmannSimon VölklJordan HartleyCeline DregerKatja PetryAndreas BosioAngelika von DöllenWolfgang HartmannHolger N LodeDennis GörlichAndreas MackensenMelanie JungblutAxel SchambachHinrich AbkenClaudia RossigPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
These results pave the way for clinical investigation of GD2IL18CART in pediatric and adult patients with neuroblastoma and other GD2-positive cancers (EU CT 2022-501725-21-00).